The medtech segment achieved operational revenue growth of 4.4% despite ongoing weaknesses in the Chinese market. Notably, ...
Johnson & Johnson plans to pay an additional $1.1 billion to resolve tens of thousands of legal actions alleging its baby ...
Johnson & Johnson is collating its pantheon of medtech brands under a single banner, to further simplify the company’s ...
Johnson & Johnson (NYSE:JNJ) is currently experiencing a mix of robust growth and notable challenges. Recent developments ...
More than a decade after taking on Johnson & Johnson with the first trial linking baby powder to ovarian cancer, attorney ...
In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Johnson & Johnson (JNJ – Research ...
Johnson Controls (NYSE: JCI), the global leader for smart, healthy and sustainable buildings, is showcasing its industry ...
Speaker Mike Johnson (R-La.) called for repealing “wasteful Green New Deal tax credits” but also said Republicans could keep ...
In a report released today, Joanne Wuensch from Citi reiterated a Buy rating on Johnson & Johnson (JNJ – Research Report). The ...
Dakota Johnson is no stranger to the sheer dress trend. In fact, it’s practically her red carpet signature at this point. If ...
Johnson & Johnson (JNJ) closed the most recent trading day at $166.99, moving +0.89% from the previous trading session. The stock's performance was ahead of the S&P 500's daily gain of 0.13%. On the ...